BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36584854)

  • 1. IFI44L as a novel epigenetic silencing tumor suppressor promotes apoptosis through JAK/STAT1 pathway during lung carcinogenesis.
    Zeng Y; Chen HQ; Zhang Z; Fan J; Li JZ; Zhou SM; Wang N; Yan SP; Cao J; Liu JY; Zhou ZY; Liu WB
    Environ Pollut; 2023 Feb; 319():120943. PubMed ID: 36584854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pro-Survival Oct4/Stat1/Mcl-1 Axis Is Associated with Poor Prognosis in Lung Adenocarcinoma Patients.
    Su YC; Chen YC; Tseng YL; Shieh GS; Wu P; Shiau AL; Wu CL
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated weighted gene co-expression network analysis uncovers STAT1(signal transducer and activator of transcription 1) and IFI44L (interferon-induced protein 44-like) as key genes in pulmonary arterial hypertension.
    Yang H; Lu Y; Yang H; Zhu Y; Tang Y; Li L; Liu C; Yuan J
    Bioengineered; 2021 Dec; 12(1):6021-6034. PubMed ID: 34516357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of XAF1 expression in human colon cancer cell by interferon beta: activation by the transcription regulator STAT1.
    Sun Y; Qiao L; Xia HH; Lin MC; Zou B; Yuan Y; Zhu S; Gu Q; Cheung TK; Kung HF; Yuen MF; Chan AO; Wong BC
    Cancer Lett; 2008 Feb; 260(1-2):62-71. PubMed ID: 18035482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.
    Arzt L; Halbwedl I; Gogg-Kamerer M; Popper HH
    Pathol Oncol Res; 2017 Jul; 23(3):595-605. PubMed ID: 27987139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
    Xi S; Dyer KF; Kimak M; Zhang Q; Gooding WE; Chaillet JR; Chai RL; Ferrell RE; Zamboni B; Hunt J; Grandis JR
    J Natl Cancer Inst; 2006 Feb; 98(3):181-9. PubMed ID: 16449678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of Immune Implication and Prognostic Value of
    Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
    Front Oncol; 2021; 11():798425. PubMed ID: 35047409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts.
    Zhang Y; Liu Z; Yang X; Lu W; Chen Y; Lin Y; Wang J; Lin S; Yun JP
    Theranostics; 2021; 11(3):1473-1492. PubMed ID: 33391546
    [No Abstract]   [Full Text] [Related]  

  • 9. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.
    Kachroo P; Lee MH; Zhang L; Baratelli F; Lee G; Srivastava MK; Wang G; Walser TC; Krysan K; Sharma S; Dubinett SM; Lee JM
    J Exp Clin Cancer Res; 2013 Nov; 32(1):97. PubMed ID: 24274066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPRY4 regulates trophoblast proliferation and apoptosis via regulating IFN-γ-induced STAT1 expression and activation in recurrent miscarriage.
    Qin S; Zhang Y; Zhang J; Tian F; Sun L; He X; Ma X; Zhang J; Liu XR; Zeng W; Lin Y
    Am J Reprod Immunol; 2020 Jun; 83(6):e13234. PubMed ID: 32196809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
    Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
    Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth.
    Hua L; Wang G; Wang Z; Fu J; Fang Z; Zhuang T; Zhao L; Zong Z; Ye C; Liu H; Zhu Y; Yu R
    J Neurooncol; 2019 May; 143(1):35-47. PubMed ID: 30993511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.
    Wu C; Molavi O; Zhang H; Gupta N; Alshareef A; Bone KM; Gopal K; Wu F; Lewis JT; Douglas DN; Kneteman NM; Lai R
    Blood; 2015 Jul; 126(3):336-45. PubMed ID: 25921060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWEAK signals through JAK-STAT to induce tumor cell apoptosis.
    Chapman MS; Wu L; Amatucci A; Ho SN; Michaelson JS
    Cytokine; 2013 Jan; 61(1):210-7. PubMed ID: 23107828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination/degradation of STAT1 in a GTP binding-dependent modality.
    Zhang L; Li Q; Yang J; Xu P; Xuan Z; Xu J; Xu Z
    Cancer Commun (Lond); 2023 Jan; 43(1):123-149. PubMed ID: 36353796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jak inhibition, but not Stat1 knockdown, blocks the synergistic effect of IFN-gamma on Fas-induced apoptosis of A549 human non-small cell lung cancer cells.
    Kurdi M; Booz GW
    J Interferon Cytokine Res; 2007 Jan; 27(1):23-31. PubMed ID: 17266440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling.
    Kaowinn S; Jun SW; Kim CS; Shin DM; Hwang YH; Kim K; Shin B; Kaewpiboon C; Jeong HH; Koh SS; Krämer OH; Johnston RN; Chung YH
    Cell Oncol (Dordr); 2017 Dec; 40(6):549-561. PubMed ID: 28776259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.